JP2022522694A5 - - Google Patents

Info

Publication number
JP2022522694A5
JP2022522694A5 JP2021549973A JP2021549973A JP2022522694A5 JP 2022522694 A5 JP2022522694 A5 JP 2022522694A5 JP 2021549973 A JP2021549973 A JP 2021549973A JP 2021549973 A JP2021549973 A JP 2021549973A JP 2022522694 A5 JP2022522694 A5 JP 2022522694A5
Authority
JP
Japan
Application number
JP2021549973A
Other languages
Japanese (ja)
Other versions
JP7704680B2 (ja
JPWO2020176757A5 (https=
JP2022522694A (ja
Filing date
Publication date
Priority claimed from US16/287,805 external-priority patent/US11098040B2/en
Application filed filed Critical
Priority claimed from PCT/US2020/020150 external-priority patent/WO2020176757A1/en
Publication of JP2022522694A publication Critical patent/JP2022522694A/ja
Publication of JP2022522694A5 publication Critical patent/JP2022522694A5/ja
Publication of JPWO2020176757A5 publication Critical patent/JPWO2020176757A5/ja
Application granted granted Critical
Publication of JP7704680B2 publication Critical patent/JP7704680B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021549973A 2019-02-27 2020-02-27 フェロトーシス誘導活性を有する化合物およびそれらの使用方法 Active JP7704680B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
USPCT/US2019/019854 2019-02-27
US16/287,805 US11098040B2 (en) 2018-02-28 2019-02-27 Compounds and methods of use
PCT/US2019/019854 WO2019168999A1 (en) 2018-02-28 2019-02-27 Compounds with ferroptosis inducing activity and methods of their use
US16/287,805 2019-02-27
US201962893092P 2019-08-28 2019-08-28
US62/893,092 2019-08-28
PCT/US2020/020150 WO2020176757A1 (en) 2019-02-27 2020-02-27 Compounds with ferroptosis inducing activity and methods of their use

Publications (4)

Publication Number Publication Date
JP2022522694A JP2022522694A (ja) 2022-04-20
JP2022522694A5 true JP2022522694A5 (https=) 2023-03-03
JPWO2020176757A5 JPWO2020176757A5 (https=) 2023-03-03
JP7704680B2 JP7704680B2 (ja) 2025-07-08

Family

ID=72238937

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021549973A Active JP7704680B2 (ja) 2019-02-27 2020-02-27 フェロトーシス誘導活性を有する化合物およびそれらの使用方法

Country Status (14)

Country Link
EP (1) EP3931183B1 (https=)
JP (1) JP7704680B2 (https=)
KR (1) KR20220012221A (https=)
CN (1) CN114008024A (https=)
AU (1) AU2020228056A1 (https=)
BR (1) BR112021016833A2 (https=)
CA (1) CA3131385A1 (https=)
EA (1) EA202192122A1 (https=)
ES (1) ES3013815T3 (https=)
IL (1) IL285730A (https=)
MX (1) MX2021010173A (https=)
SG (1) SG11202109035QA (https=)
TW (1) TW202045480A (https=)
WO (1) WO2020176757A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10118890B2 (en) 2014-10-10 2018-11-06 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
TW202000663A (zh) 2018-02-28 2020-01-01 美商費洛醫療公司 化合物及使用方法
US11040964B2 (en) 2019-02-27 2021-06-22 Ferro Therapeutics, Inc. Compounds and methods of use
TW202227399A (zh) * 2020-08-26 2022-07-16 美商費洛醫療公司 化合物及使用方法
KR102759930B1 (ko) * 2022-01-17 2025-01-23 포항공과대학교 산학협력단 Marh6(marchf6) 조절제를 포함하는, 페로토시스 조절용 조성물 및 방법
WO2024015637A1 (en) * 2022-07-15 2024-01-18 Ferro Therapeutics, Inc. Glutathione peroxidase 4 (gpx4) inhibitors for the treatment of cancer
CN114984019B (zh) * 2022-07-15 2023-08-22 山东中医药大学 一种铁死亡抑制剂化合物及在肝损伤修复领域的应用
CN117209521A (zh) * 2022-11-04 2023-12-12 台州道致科技股份有限公司 丙炔酰氯制备方法
CN116983310B (zh) * 2023-08-29 2024-04-30 南方医科大学南方医院 一种治疗肝癌的药物组合物及其应用
CN118047698A (zh) * 2024-01-30 2024-05-17 山东科巢生物制药有限公司 一种n-[(1r)-2-[1,1'-联苯]-4-基-1-(羟基甲基)乙基]氨基甲酸叔丁酯的制备方法
CN118994147B (zh) * 2024-07-18 2026-01-02 中国海洋大学 一种基于疏水标签的gpx4蛋白降解剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03004023A (es) * 2000-11-08 2004-02-12 Lilly Icos Llc Compuestos quimicos.
EP3791870A1 (en) * 2013-12-02 2021-03-17 The Trustees of Columbia University in the City of New York Modulating ferroptosis and treating excitotoxic disorders
AU2016311426B2 (en) * 2015-08-26 2021-05-20 Blueprint Medicines Corporation Compounds and compositions useful for treating disorders related to NTRK
US20190008961A1 (en) * 2016-01-07 2019-01-10 The Broad Institute, Inc. Compounds and methods for increasing tumor infiltration by immune cells
WO2018118711A1 (en) * 2016-12-19 2018-06-28 The Trustees Of Columbia University In The City Of New York Small molecule ferroptosis inducers
TW202000663A (zh) * 2018-02-28 2020-01-01 美商費洛醫療公司 化合物及使用方法
JP2023509359A (ja) * 2019-12-17 2023-03-08 フラグシップ パイオニアリング イノベーションズ ブイ,インコーポレーテッド 鉄依存性細胞分解の誘導物質との併用抗癌療法
CN113336748B (zh) * 2021-04-12 2022-03-25 北京大学 一种gpx4蛋白降解剂及其制备方法和应用、一种抗肿瘤细胞药物

Similar Documents

Publication Publication Date Title
JP2022522694A5 (https=)
CN306024252S (https=)
CN305813086S (https=)
CN305591114S (https=)
CN305591689S (https=)
CN305592071S (https=)
CN305595153S (https=)
CN305639893S (https=)
CN305640968S (https=)
CN305651582S (https=)
CN305652140S (https=)
CN305653230S (https=)
CN305653314S (https=)
CN305653485S (https=)
CN305674284S (https=)
CN305676333S (https=)
CN305676421S (https=)
CN305700602S (https=)
CN305710720S (https=)
CN305715338S (https=)
CN305725715S (https=)
CN305734422S (https=)
CN305742637S (https=)
CN305742782S (https=)
CN305748794S (https=)